MSOS stock and what to expect next with MSOS stock

Gene insertion startup Tome Biosciences stops lab work as CEO shifts focus to deal talks

Tome Biosciences, a high-profile gene editing startup spun out of MIT, is halting its lab work and looking to sell itself or find a partner

August 24, 2024

PharmaDrug Announces Amendment to Shareholder Meeting Matter | Psychedelic Invest

PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company“), announced today that, further to its press release dated September 6, 2023, Mr. Daniel Cohen

September 20, 2023

Cybin CEO AMA: Patents, DMT Trials, Timelines and Raising Capital in a Recession | CYBN Stock

July 29, 2022

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.